Perimenopause

Perimenopause is the hormonal transition that precedes menopause, typically starting in the late 30s or 40s and lasting 4 to 10 years. It ends 12 months after the final menstrual period, at which point a person is technically postmenopausal. During perimenopause, ovarian reserve declines and the predictable rhythm of the menstrual cycle breaks down.

This is informational, not medical advice. Perimenopause symptoms can overlap with thyroid, mood, and other conditions. Evaluation by a qualified provider is appropriate when symptoms are disruptive.

How perimenopause is recognized

There is no single blood test that confirms perimenopause. FSH and estrogen fluctuate wildly during the transition, so a single lab value is rarely conclusive. Diagnosis is clinical, based on:

  • Age (typically 40 and over, sometimes earlier)
  • Cycle changes (length, regularity, flow)
  • Vasomotor symptoms (hot flashes, night sweats)
  • Sleep and mood changes
  • Genitourinary symptoms (vaginal dryness, urinary frequency)

The STRAW+10 staging system divides the transition into early and late perimenopause based on cycle variability and symptoms.

How cycles change

The classic perimenopause sequence:

  1. Cycles shorten. The follicular phase shortens first as follicle pools shrink and FSH rises earlier. A 28-day cycle may become 25 days, then 22.
  2. Cycles become irregular. Skipped ovulations produce occasional long cycles, while quick turnarounds produce short ones. Variability rises.
  3. Anovulatory cycles increase. Anovulatory cycles become more common, contributing to heavy or unpredictable bleeding.
  4. Cycles space out. Gaps of 60 or more days mark late perimenopause.
  5. Menopause. 12 consecutive months without a period.

The luteal phase tends to stay close to 14 days until late perimenopause, when it can shorten as well.

Common symptoms

  • Cycle changes (length, flow, regularity).
  • Hot flashes and night sweats.
  • Sleep disruption, often independent of vasomotor symptoms.
  • Mood changes, including new-onset anxiety, irritability, and depressive symptoms.
  • Brain fog and difficulty with word retrieval.
  • Vaginal dryness and painful intercourse.
  • Urinary frequency or urgency.
  • Joint and muscle aches.
  • Skin and hair changes.
  • Weight redistribution, particularly central.
  • Heavier or unpredictable bleeding from anovulatory cycles.

Symptom timing matters. Many users notice premenstrual symptoms intensify (or appear new) in early perimenopause, before cycle length even changes.

The underlying biology

Perimenopause is driven by declining ovarian reserve. As the pool of remaining follicles shrinks, the brain compensates by raising FSH to recruit them. The resulting hormonal pattern is paradoxical: estrogen can be high, low, or wildly swinging, often within the same cycle.

Progesterone declines more steadily as ovulation becomes less reliable. Loss of cyclic progesterone underlies many of the early symptoms (sleep, anxiety, heavier bleeding from unopposed estrogen).

Cycle syncing in perimenopause

The four-phase model assumes a predictable cycle. In perimenopause, calendar-based predictions become increasingly unreliable.

Practical adaptations:

  • Track ovulation directly. Use basal body temperature or OPKs to detect ovulation when it happens rather than guess by date.
  • Track symptoms in their own right. A symptom log often shows that vasomotor and mood symptoms peak just before bleeding, when estrogen falls.
  • Plan in 3-month windows, not 28-day cycles. Look at trends in cycle length and symptom severity over time rather than expecting a clean monthly rhythm.
  • The follicular phase lift may shrink. Don't over-rely on a strong early-cycle window; some users find the lift muted or shortened.
  • The constrained-practice guide at cycle syncing in perimenopause covers detailed adaptations.

Treatment angles

Treatment depends on symptom severity and personal preferences:

  • Lifestyle. Sleep hygiene, resistance training, stress management, and nutrition support symptom control.
  • Menopausal hormone therapy (formerly HRT, now MHT or HRT) for vasomotor and genitourinary symptoms.
  • Low-dose hormonal contraceptives can stabilize cycles in early perimenopause.
  • Vaginal estrogen for local genitourinary symptoms with minimal systemic absorption.
  • SSRIs or SNRIs for vasomotor symptoms when hormones are contraindicated.
  • Cognitive behavioral therapy for menopause has evidence for hot flashes and sleep.

All of these should be coordinated with a provider.

Perimenopause and the menstrual cycle

A few practical implications:

  • Expect variability; a "regular" cycle is no longer the baseline.
  • Heavy bleeding warrants evaluation (anovulatory cycles, fibroids, hyperplasia).
  • Symptom severity often peaks in late perimenopause and improves after menopause.
  • Cycle syncing transitions from a prescriptive practice to a pattern-recognition tool during this stage.

Related reading